The Additive Value of 3D Total Body Imaging for Sequential Monitoring of Skin Lesions: A Case Series.


Journal

Dermatology (Basel, Switzerland)
ISSN: 1421-9832
Titre abrégé: Dermatology
Pays: Switzerland
ID NLM: 9203244

Informations de publication

Date de publication:
2022
Historique:
received: 10 12 2020
accepted: 05 06 2021
pubmed: 12 8 2021
medline: 26 2 2022
entrez: 11 8 2021
Statut: ppublish

Résumé

Timely diagnosis is the cornerstone of melanoma morbidity and mortality reduction. 2D total body photography and dermoscopy are routinely used to assist with early detection of skin malignancies. Polarized 3D total body photography is a novel technique that enables fast image acquisition of almost the entire skin surface. We aimed to determine the added value of 3D total body photography alongside dermoscopy for monitoring cutaneous lesions. Lesion images from high-risk individuals were assessed for long-term substantial changes via dermoscopy and 3D total body photography. Three case studies are presented demonstrating how 3D total body photography may enhance lesion analysis alongside traditional dermoscopy. 3D total body photography can assist clinicians by presenting cutaneous lesions in their skin ecosystem, thereby providing additional clinical context and enabling a more holistic assessment to aid dermoscopy interpretation. For lesion cases where previous dermoscopy is unavailable, corresponding 3D images can substitute for baseline dermoscopy. Additionally, 3D total body photography is not susceptible to artificial stretch artefacts. 3D total body photography is valuable alongside dermoscopy for monitoring cutaneous lesions. Furthermore, it is capable of surveilling almost the entire skin surface, including areas not traditionally monitored by sequential imaging.

Sections du résumé

BACKGROUND BACKGROUND
Timely diagnosis is the cornerstone of melanoma morbidity and mortality reduction. 2D total body photography and dermoscopy are routinely used to assist with early detection of skin malignancies. Polarized 3D total body photography is a novel technique that enables fast image acquisition of almost the entire skin surface. We aimed to determine the added value of 3D total body photography alongside dermoscopy for monitoring cutaneous lesions.
METHODS METHODS
Lesion images from high-risk individuals were assessed for long-term substantial changes via dermoscopy and 3D total body photography. Three case studies are presented demonstrating how 3D total body photography may enhance lesion analysis alongside traditional dermoscopy.
RESULTS RESULTS
3D total body photography can assist clinicians by presenting cutaneous lesions in their skin ecosystem, thereby providing additional clinical context and enabling a more holistic assessment to aid dermoscopy interpretation. For lesion cases where previous dermoscopy is unavailable, corresponding 3D images can substitute for baseline dermoscopy. Additionally, 3D total body photography is not susceptible to artificial stretch artefacts.
CONCLUSION CONCLUSIONS
3D total body photography is valuable alongside dermoscopy for monitoring cutaneous lesions. Furthermore, it is capable of surveilling almost the entire skin surface, including areas not traditionally monitored by sequential imaging.

Identifiants

pubmed: 34380140
pii: 000517900
doi: 10.1159/000517900
pmc: PMC8820426
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

12-17

Informations de copyright

© 2021 The Author(s). Published by S. Karger AG, Basel.

Références

Br J Dermatol. 2004 Apr;150(4):706-14
pubmed: 15099367
Arch Dermatol. 2005 Apr;141(4):434-8
pubmed: 15837860
Arch Dermatol. 2005 Jun;141(6):745-50
pubmed: 15967921
Med J Aust. 1997 Aug 18;167(4):191-4
pubmed: 9293264
BMJ Open. 2019 Nov 10;9(11):e032969
pubmed: 31712348
Front Med (Lausanne). 2018 May 23;5:152
pubmed: 29911103
J Am Acad Dermatol. 2013 Apr;68(4):568-575
pubmed: 23182058
Dermatol Surg. 2005 Feb;31(2):169-72
pubmed: 15762209
J Am Acad Dermatol. 2012 Jul;67(1):e17-27
pubmed: 21683472
Arch Dermatol. 2006 Dec;142(12):1551-8
pubmed: 17178980
Am J Dermatopathol. 1996 Apr;18(2):137-41
pubmed: 8739987
J Invest Dermatol. 2006 May;126(5):980-5
pubmed: 16514414
JAMA Dermatol. 2017 Apr 1;153(4):279-284
pubmed: 28196213
JAMA Dermatol. 2013 Jun;149(6):699-709
pubmed: 23553375
Arch Dermatol. 1998 Jan;134(1):103-4
pubmed: 9449921
BMJ Open. 2018 Sep 19;8(9):e025857
pubmed: 30232117

Auteurs

Katarzyna Grochulska (K)

University of Queensland Diamantina Institute, University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia.
Dermatology Department, Medical University of Graz, Graz, Austria.

Brigid Betz-Stablein (B)

University of Queensland Diamantina Institute, University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia.
Cancer and Population Studies, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Chantal Rutjes (C)

University of Queensland Diamantina Institute, University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia.

Frank Po-Chao Chiu (FP)

University of Queensland Diamantina Institute, University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia.

Scott W Menzies (SW)

Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital and Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.

H Peter Soyer (HP)

University of Queensland Diamantina Institute, University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia.
Dermatology Department, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

Monika Janda (M)

Centre of Health Services Research, Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia, m.janda@uq.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH